跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CGT-2
首页
药物
CGT-2
CGT-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes
US 7339040 B2
申请人: ELEA S A C I F Y A LAB
优先权: 2003
US
2 件公开
含有2-O-α-D-葡萄糖基-L-抗坏血酸无水结晶的粉末的制造方法
CN 106220696 B
申请人: 株式会社林原
优先权: 2011
CN
2 件公开
Method for Producing Yellow Flower by Controlling Flavonoid Synthetic Pathway
US 2008009032 A1
申请人: TANAKA YOSHIKAZU
优先权: 2003
US
DNA fragment related to pig polydactyly
CN 101157923 A
申请人: CHONGQING ACADEMY OF ANIMAL HU
优先权: 2007
CN
DKAT CELL LINE, A MODEL FOR HUMAN TRIPLE-NEGATIVE BREAST CANCER
US 2011085982 A1
申请人: DUKE UNIVERSITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
优先权: 2010
US
PROCESS FOR PRODUCING pPIC9K-KEX2 RECOMBINANT PLASMIDS IN ESCHERICHIA COLI BACTERIAL CELLS FOR CO-EXPRESSION IN THE YEAST PICHIA PASTORIS
WO 2024252380 A1
申请人: BADAN RISET DAN INOVASI NASIONAL BRIN
优先权: 2023
WO
B-CGT hydrogel as well as preparation method and application thereof
CN 119925262 A
申请人: GUIZHOU UNIV OF TRADITIONAL CHINESE MEDICINE
优先权: 2025
CN
药物
反馈